The bond proceeds of $360 million will be used for construction, renovation and expansion projects at the system’s facilities.
The rating assignment was based on a number of factors, including Texas Health’s very good operating results and leading market share, according to Kevin Holloran, an S&P credit analyst.
The system’s outlook is stable, which reflects S&P’s expectation that Texas Health will continue its track record of solid operating income levels and also continue to prepare for population health management.
More articles on healthcare finance:
The $253M battle between 2 Illinois hospitals
Erlanger profit increases on higher patient volume
Mercy Health’s profit plummets 62% in 2014
